From:  How algorithms are transforming the diagnosis of ischemic heart disease—state of the art

 AI systems and platforms in clinical practice.

System/PlatformTechnology/MethodAI performanceClinical validationImplementation timeRegulatory statusReferences
AVVIGO+Automated HD-IVUS assessment with real-time lumen/vessel/plaque morphology analysisAccuracy: 85% (lumen boundaries), 97% (stent area)Validated against expert manual measurements in multicenter studiesReal-time (< 1 min per pullback)FDA cleared, CE marked[22]
Ultreon OCTAI-powered lumen segmentation with automated stent sizing and landing zone recommendationsHigh concordance with expert analysis; automated workflow guidanceClinical studies demonstrate improved procedural efficiency and standardizationImmediate (during procedure)FDA cleared, CE marked[39]
PROTEUSAI-assisted stress echocardiography interpretation with automated wall motion scoringNon-inferior to standard practice (primary endpoint met); AUC 0.87–0.91Randomized controlled trial; improved inter-reader consistency, especially for less-experienced operators< 5 min additional analysis timeUnder clinical investigation[40]

AI: artificial intelligence; AUC: area under the curve; CE: Conformité Européenne; FDA: Food and Drug Administration; HD-IVUS: high-definition intravascular ultrasound; iFR: instantaneous wave‑free ratio; OCT: optical coherence tomography.